Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin

American Journal of Pathology

Volumn 151, Issue 5, 1997, Pages 1321-1329

  Wrone Smith, Tamara ^a   Mitra, Raj S ^b   Thompson, Craig B ^c   Jasty, Rama ^b   Castle, Valerie P ^b   Nickoloff, Brian J ^a,d  

^a LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL ULTRASTRUCTURE; CYTOARCHITECTURE; DNA SYNTHESIS; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; PSORIASIS;

APOPTOSIS; CELL LINE; DNA; DNA FRAGMENTATION; GENETIC TECHNIQUES; HUMANS; KERATINOCYTES; KI-67 ANTIGEN; METHYLCELLULOSE; PROLIFERATING CELL NUCLEAR ANTIGEN; PSORIASIS; REFERENCE VALUES; SKIN;

EID: 0030716227     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. McKay JA, Leigh IM: Altered keratinocyte growth and differentiation in psoriasis. Clin Dermatol 1975, 13:105-144
2. Wrone-Smith T, Johnson T, Nelson B, Boise LH, Thompson CB, Nunez G, Nickoloff BJ: Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995, 146:1079-1088
3. Haake AR, Polakowska RR: Cell death by apoptosis in epidermal biology. J Invest Dermatol 1993, 101:107-112
4. McCall CA, Cohen JJ: Programmed cell death in terminally differentiating keratinocytes: role of endogenous endonuclease. J Invest Dermatol 1995, 97:111-114
5. Potten CS, Hendry JH: Clonogenic cells and stem cells in the epidermis. Int J Radiat Biol 1973, 24:537-540
6. Gavrieli Y, Sherman Y, Ben Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear fragmentation. J Cell Biol 1992, 119:493-501
7. Bohr V, Mansbridge J, Hanawalt P: Comparative effects of growth inhibitors on DNA regulation, DNA repair, and protein synthesis in human epidermal keratinocytes. Cancer Res 1986, 46:2929-2935
8. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kB fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 1993, 12:3679-3684
9. Ryle C, Breitkreutz D, Stark H, Leigh I, Steinert P, Roop D, Fusenig N: Density-dependent modulation of synthesis of keratins 1 + 10 in the human keratinocyte line HaCat and in ras-transfected tumorigenic clones. Differentiation 1989, 40:42-54
10. Nickoloff BJ, Fisher GS, Mitra RS, Voorhees JJ: Additive and synergistic antiproliferative effects of cyclosporin A and γ-interferon on cultured human keratinocytes. Am J Pathol 1988, 131:12-18
11. Sadek CM, Allen-Hoffman BL: Cytochrome P450IA1 is rapidly induced in normal human keratinocytes in the absence of xenobiotics. J Biol Chem 1994, 269:16067-16074
12. Mitra RS, Wrone-Smith T, Simonian P, Foreman KE, Nunez G, Nickoloff BJ: Apoptosis in keratinocytes is not dependent on induction of differentiation. Lab Invest 1997, 76:99-107
13. Sachsenmeier K, Sheibani N, Schlosser SJ, Allen-Hoffman BL: Transforming growth factor-β1 inhibits nucleosomal fragmentation in human keratinocytes following loss of adhesion. J Biol Chem 1996, 271:5-8
14. L is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis. Cancer Res 1995, 55:2575-2582
15. Kurki P, Vanderlaan M, Dolbeare F, Gray J, Tan EM: Expression of proliferating cell nuclear antigen (PCNA)/cyclin during the cell cycle. Exp Cell Res 1986, 166:209-219
16. Schluter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad HD, Gerdes J: The cell proliferation-associated antigen of antibody Ki67: a very large ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993, 123:513-522
17. Gorczyca W, Bignan K, Mittelman A, Ahmed T, Gong J, Melamed MR, Darzynkiewicz Z: Detection of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993, 7:659-670
18. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD: Flow cytometric identification of proliferate subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993, 178:1271-1281
19. Bianchi L, Farrace MG, Nini G, Piacentini M: Abnormal Bcl-2 and "tissue" transglutaminase expression in psoriatic skin. J Invest Dermatol 1994, 103:829-833
20. McCormick D, Hall PA: The complexities of proliferating cell nuclear antigen. Histopathology 1992, 21:591-594
21. Van Scott J, Ekel TM: Kinetics of hyperplasia in psoriasis. Arch Dermatol 1963, 88:373-381
22. Bergstresser PR, Taylor JR: Epidermal turnover time: a new examination. Br J Dermatol 1977, 96:503-506
23. Leigh IM, Navasaria H, Purkis PE, McKay IA, Bowden PE, Riddle PN: Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. Br J Dermatol 1995, 133:501-511
24. Hockenberry DM, Zutter M, Hickey W, Hahn M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991, 88:6961-6965
25. Polakowska RR, Haake AR: Apoptosis: the skin from a new perspective. Cell Death Differ 1994, 1:19-31
26. Liang XH, Mungal S, Ayscue A, Meissner JD, Wodnicki P, Hockenberry D, Lockett S, Herman B: Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J Cell Biochem 1995, 57:509-521
27. Gottlieb AB, Chang CK, Posnett ND, Tam JP: Detection of TGFα in normal, malignant and hyperproliferative human keratinocytes. J Exp Med 1988, 167:670-675
28. Elder JT, Fisher GJ, Lindquist PB, Voorhees JJ: Over-expression of transforming growth factor α in psoriatic epidermis. Science 1989, 243:811-814
29. Smith GH, Sharp R, Kordon EC, Jhappan C, Merlino G: Transforming growth factor-α promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol 1995, 147:1081-1096
30. Hines MD, Allen-Hoffman BL: Keratinocyte growth factor inhibits cross-linked envelope formation and nucleosomal fragmentation in cultured human keratinocytes. J Biol Chem 1996, 271:6245-6251
31. Potten CS: Possible defects in the proliferative organization and control mechanisms in psoriasis. Psoriasis: Proceedings of the Fourth International Symposium. Edited by EM Farber, L Nall, V Morhenn, PN Jacobs. New York, Elsevier, 1986, pp 15-35
32. Krueger JG, Wolfe JT, Nabeya RT, Vallat VP, Gilleaudeau P, Heftler NS, Austin LM, Gottlieb AB: Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 1995, 182:2057-2068
33. Gottlieb AB, Krueger JG: The role of activated T lymphocytes in the pathogenesis of psoriasis. Psoriasis. Edited by L Dubertret. Brescia, Italy, ISED, 1993, pp 63-71
34. Mansbridge J, Reusch M, Bohr V, Hanawalt P: The wound-healing model of psoriasis, the "psoriagene", and rational approaches to therapy. Psoriasis: Proceedings of the Fourth International Symposium. Edited by EM Farber, L Nall, V Morhenn, PN Jacobs. New York, Elsevier, 1986, pp 294-301
35. Cellis JE, Madsen P: Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision repair. FEBS 1996, 209:277-283
36. Hall PA, Levison DA, Woods AL, Yu CC, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP: Proliferating cell nuclear antigen immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 1996, 162:285-294
37. Okazaki R, Okazaki T, Sakabe K, Sugimoto K, Sugino A: Mechanism of DNA chain growth: possible discontinuity and unusual secondary structure of newly synthesized chains. Proc Natl Acad Sci USA 1968, 59:598-605
38. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, DiLoreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 1997, 366:1131-1141
39. Pandey S, Wang E: Cells en route to apoptosis are characterized by the upregulation of c-fos, c-myc, c-jun, cdc2, and RB phosphorylation, resembling events of early cell-cycle traverse. J Cell Biochem 1995, 58:135-150
40. Hengartner MO: Programmed cell death: a rich harvest. Curr Biol 1994, 4:950-952
41. Seiberg M, Marthinuss J, Stenn KS: Changes in expression of apoptosis-associated genes in skin mark early catagen. J Invest Dermatol 1995, 104:78-82